The aim of the study was to measure the effects on blood pressure ( BP ) of the angiotensin receptor blocker azilsartan medoxomil , in 40 and 80 mg doses , combined with 5 mg of the calcium channel blocker amlodipine and to compare these effects with placebo plus amlodipine 5 mg .